Study of effectiveness of photodynamic therapy for PC-1 experimental tumors with a liposomal form of boronated derivative of chlorine e6 photosensitizer

«Radiation and Risk», 2016, vol. 25, No. 3, pp.57-65

DOI: 10.21870/0131-3878-2016-25-3-57-65


Kaplan M.A.1 – Head of Dep., MD, Prof. A. Tsyb MRRC, Obninsk, Russia. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249036. Tel.: +7 (484) 399-30-26; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Galkin V.N.1 – Director, MD, Prof. Tsyb MRRC, Obninsk, Russia.
Romanko Yu.S.1 – Head of Dep., MD, Prof. A. Tsyb MRRC, Obninsk, Russia.
Osipchuk Yu.S.1 – Research Assistant. A. Tsyb MRRC, Obninsk, Russia.
Drozhzhina V.V.1 – Research Assistant. A. Tsyb MRRC, Obninsk, Russia.
Malova T.I.2 – Director. LLC “VETA-GRAND.
Ol'shevskaya V.A.3 – Senior Researcher, C. Sc., Chem. INEOS RAS.


For studies inbred rats with subcutaneously implanted liver cancer alveolar PC-1 were used. The aim of this study was to investigate the dynamics of the accumulation of liposomal form of borated chlorin e6 in the tumor and healthy tissue to determine the optimal time for the photodynamic therapy, and to evaluate the effectiveness of photodynamic therapy with the photosensitizer depending on its dose: in the group I the photosensitizer was administered at the dose of 2.5 mg/kg, in the group II the dose was 5.0 mg/kg. Laser radiation parameters delivered to both groups were similar (E energy density was 150 J/cm2, power density Ps – 0.25 W/cm2). Efficiency of the treatment was assessed by completeness of tumor regression, rate of tumor growth in animals with continued tumor growth. As a result of the study optimal time for photodynamic therapy following administration of the photosensitizer was found to be 2.5 hours, and the effective dose – 5 mg/kg. Experimental results suggest possibility to increase therapeutic efficiency of laser radiation with the use of a liposomal form of borone derivative of chlorine e6.

Key words
photodynamic therapy, photosensitizer, chlorin e6 borated, liposomal form, the laser radiation, alveolar carcinoma of the liver, the ratio of the absolute growth of the tumor, the rate of tumor growth inhibition, complete regression, index contrast.


1. Ackroyd R., Kelty C., Brown N., Reed M. The history of photodetection and photodynamic therapy. Photochem. Photobiol., 2001, vol. 74, no. 5, pp. 656-669.

2. Foote C.S. Definition of type I and type II photosensitized oxidation. Photochem. Photobiol., 1991, no. 54, pp. 659-672.

3. Hatz S., Lambert J.D., Ogilby P.R. Measuring the lifetime of singlet oxygen in a single cell: addressing the issue of cell viability. Photochem. Photobiol. Sci., 2007, vol. 6, no. 10, pp. 1106-1116.

4. Niedre M., Patterson M.S., Wilson B.C. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem. Photobiol., 2002, vol. 75, no. 4, pp. 382-391.

5. Bonnett R. Chemical Aspects of Photodynamic Therapy. Amsterdam, Gordon and Breach Science Publishers, 2000. 324 p.

6. Ben-Hur E., Geacintov N.E., Studamire B., Kenney M.E., Horowitz B. The effect of irradiance on virus sterilization and photodynamic damage in red blood cells sensitized by phtalocyanines. Photochem. Photobiol., 1995, vol. 61, no. 2, pp. 190-195.

7. Zhang D., Wu M., Zeng Y., Wu L., Wang Q., Han X., Liu X., Liu J. Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy. ACS Appl. Mater. Interfaces, 2015, vol. 7, no. 15, pp. 8176-8187.

8. Konan Y.N., Gurny R., Allémann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B: Biology, 2002, vol. 66, no. 2, pp. 89-106.

9. Polo L., Valduga G., Jori G., Reddi E. Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts. Int. J. Biochem. Cell. Biol., 2002, vol. 34, no. 1, pp. 10-23.

10. Dougherty T.J., Sumlin A.B., Greco W.R., Weishaupt K.R., Vaughan L.A., Pandey R.K. The role of the peripheral benzodiazepine receptor in photodynamic activity of certain pyropheophorbide ether photosensitizers: albumin site II as a surrogate marker for activity. Photochem. Photobiol., 2002, vol. 76, no. 1, pp. 91-97.

11. Swamy N., James D.A., Mohr S.C., Hanson R.N., Ray R. An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells. Bioorg. Med. Chem., 2002, vol. 10, no. 10, pp. 3237-3243.

12. El-Daly S.M., Gamal-Eldeen A.M., Abo-Zeid M.A., Borai I.H., Wafay H.A., Abdel-Ghaffar A.R. Photodynamic therapeutic activity of indocyanine green entrapped in polymeric nanoparticles. Photodiagnosis Photodyn. Ther., 2013, vol. 10, no. 2, pp. 173-185.

13. Jin S., Zhou L., Gu Z., Tian G., Yan L., Ren W., Yin W., Liu X., Zhang X., Hu Z., Zhao Y. A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells. Nanoscale, 2013, vol. 5, no. 23, pp. 11910-11918.

14. Smirnova Z.S., Oborotova N.A., Makarova O.A., Orlova O.L., Polozkova A.P., Kubasova I.Y., Luk'yanets E.A., Meerovich G.A., Zimakova N.I., Kuz'min S.G., Vorozhtsov G.N., Baryshnikov A.Y. Efficiency and pharmacokinetics of photosense: a new liposomal photosensitizer formulation based on aluminum sulfophthalocyanine. Pharm. Chem. J., 2005, vol. 39, no. 7, pp. 341-344.

15. Damoiseau X., Schuitmaker H.J., Lagerberg J.W., Hoebeke M. Increase of the photosensitizing efficiency of the Bacteriochlorin a by liposome-incorporation. J. Photochem. Photobiol. B., 2001, vol. 60, no. 1, pp. 50-60.

16. Lang K., Mosinger J., Wagnerová D.M. Photophysical properties of porphyrinoid sensitizers non-covalently bound to host molecules; models for photodynamic therapy. Coord. Chem. Rev., 2004, no. 248, pp. 321-350.

17. Hoebeke М. The importance of liposomes as models and tools in the understanding of photosensitization mechanisms. J. Photochem. Photobiol., B Biol., 1995, no. 28, pp. 189-196.

18. Bourré L., Thibaut S., Fimiani M., Ferrand Y., Simonneaux G., Patrice T. In vivo photosensitizing efficiency of a diphenylchlorin sensitizer: interest of a DMPC liposome formulation. Pharmacol. Res., 2003, no. 47, pp. 253-261.

19. Igarashi A., Konno H., Tanaka T., Nakamura S., Sadzuka Y., Hirano T., Fujise Y. Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer. Toxicol. Lett., 2003, vol. 145, no. 2, pp. 133-141.

20. Derycke A.S., de Witte P.A. Liposomes for photodynamic therapy. Adv. Drug. Deliv. Rev., 2004, vol. 56, no. 1, pp. 17-30.

Full-text article (in Russian)